Cargando…
Aberrant expression of plasma microRNA-33a in an atherosclerosis-risk group
In order to investigate whether plasma microRNA-33a (miR-33a) can be a biomarker for the early detection of atherosclerosis and to reexamine the assumption that miR-33a represses the expression of ABCA1, we compared the expression levels of miR-33a and ATP-binding cassette A1 (ABCA1) using human pla...
Autores principales: | Kim, Soo Hwan, Kim, Gi Jin, Umemura, Tsukuru, Lee, Seung Gwan, Cho, Kyung Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310570/ https://www.ncbi.nlm.nih.gov/pubmed/27664032 http://dx.doi.org/10.1007/s11033-016-4082-z |
Ejemplares similares
-
Circulating microRNAs in malaria infection: bench to bedside
por: Chamnanchanunt, Supat, et al.
Publicado: (2017) -
Is microRNA-33 an Appropriate Target in the Treatment of Atherosclerosis?
por: Sidorkiewicz, Malgorzata
Publicado: (2023) -
Plasma microRNA-451 as a novel hemolytic marker for β(0)-thalassemia/HbE disease
por: Leecharoenkiat, Kamonlak, et al.
Publicado: (2017) -
Aberrantly expressed microRNAs in the context of bladder tumorigenesis
por: Lee, Jong-Young, et al.
Publicado: (2016) -
Identification of Differential Roles of MicroRNA‐33a and ‐33b During Atherosclerosis Progression With Genetically Modified Mice
por: Koyama, Satoshi, et al.
Publicado: (2019)